Docosapentaenoic acid (DPA) designates any straight open chain polyunsaturated fatty acid (PUFA) which contains 22 carbons and 5 double bonds. DPA is primarily used to designate two isomers, all-cis-4,7,10,13,16-docosapentaenoic acid (i.e. 4Z,7Z,10Z,13Z,16Z-docosapentaenoic acid) and all-cis-7,10,13,16,19-docosapentaenoic acid (i.e. 7Z,10Z,13Z,16Z,19Z-docosapentaenoic acid). They are also commonly termed nâÂÂ6 DPA and nâÂÂ3 DPA, respectively; these designations describe the position of the double bond being 6 or 3 carbons closest to the (omega) carbon at the methyl end of the molecule and is based on the biologically important difference that nâÂÂ6 and nâÂÂ3 PUFA are separate PUFA classes, i.e. the omega-6 fatty acids and omega-3 fatty acids, respectively. Mammals, including humans, can not interconvert these two classes and therefore must obtain dietary essential PUFA fatty acids from both classes in order to maintain normal health (see essential fatty acids).
The two isomers osbond acid and clupanodonic acid have the same number of double bonds, but on different positions along the chain, so they are regioisomers.
nâÂÂ6 DPA is an ÃÂ-6 fatty acid with the trivial name osbond acid. It is formed in two steps from eicosatetraenoic acid (5,8,11,14-20:4nâÂÂ6 or arachidonic acid, AA). Arachidonic acid is elongated to docosatetraenoic acid (7,10,13,16-22:4nâÂÂ6 or adrenic acid, AdA), which in turn is converted by ÃÂ4-desaturase to osbond acid.
nâÂÂ3 DPA is an nâÂÂ3 fatty acid with the trivial name clupanodonic acid. It is an intermediate compound between eicosapentaenoic acid (EPA 5,8,11,14,17-20:5nâÂÂ3 or timnodonic acid) and docosahexaenoic acid (DHA 4,7,10,13,16,19-22:6nâÂÂ3 or cervonic acid) in the metabolic pathway of DHA in eucaryotes. Eicosapentaenoic acid is elongated to clupanodonic acid, which in turn is converted by ÃÂ4-desaturase to docosahexaenoic acid 22:6nâÂÂ3 (see ).
Mammalian cells, including human cells, metabolize nâÂÂ3 DPA to an array of products that are members of the specialized proresolving mediators class of PUFA metabolites. These metabolites include four resolvins of T series and three of D series (RvT1, RvT2, RvT3, RvT4, RvD1<sub>nâÂÂ3</sub>, RvD2<sub>nâÂÂ3</sub>, and RvD5<sub>nâÂÂ3</sub> (do not confuse with D series resolvins derived from DHA); see and Resolvin), two protectins (PD1<sub>nâÂÂ3</sub> and PD2<sub>nâÂÂ3</sub>; see and Neuroprotectin), and three maresins (MaR1<sub>nâÂÂ3</sub>, MaR2<sub>nâÂÂ3</sub>, and MaR3<sub>nâÂÂ3</sub>; see and Maresin).
These are the top five sources for nâÂÂ3 DPA according to the USDA Agricultural Research Service:
Seal meat and human breast milk are rich in nâÂÂ3 DPA.
nâÂÂ3 DPA (clupanodonic acid) along with its metabolite DHA and other long chain omega-3 fatty acids, is under study to determine properties of omega-3 fats in humans, such as in inflammation mechanisms.